{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreigavx6sopmo4opwyfmlxfilshyc2my3ocwu5ozomhq4rrhzxkncsm",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mnjncepx4u22"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreid55wde2uaaz4jw6ek5bv33xv4j7rpvqawsp7ajfhabb4sjd452xa"
    },
    "mimeType": "image/jpeg",
    "size": 172473
  },
  "path": "/pharmalot/2026/06/04/hikma-amarin-generics-skinny-labeling-supreme-court/?utm_campaign=rss",
  "publishedAt": "2026-06-04T18:04:23.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Pharmalot",
    "legal",
    "Pharmaceuticals",
    "Policy",
    "STAT+",
    "Supreme Court"
  ],
  "textContent": "The Supreme Court unanimously ruled that Hikma Pharmaceutical did not infringe patents held by Amarin in a decision with implications for lawsuits over so-called skinny labels.",
  "title": "STAT+: Supreme Court backs generic drugmaker in ‘skinny labeling’ case",
  "updatedAt": "2026-06-05T02:50:08.000Z"
}